By the BossCE Editorial Team.
Key Points
- Dengue runs in three phases: febrile, critical and recovery. The critical phase usually starts around defervescence and lasts 24–48 hours. A patient whose fever has just settled is not yet safe [1][4].
- Warning signs usually appear late in the febrile phase, around defervescence. Any warning sign means inpatient care [1][2][4].
- Admission also depends on who the patient is: pregnancy, older age, comorbidities, antiplatelet or anticoagulant use and poor access to follow-up all lower the threshold [2][4].
- Give paracetamol, not NSAIDs or aspirin. Do not give prophylactic platelet transfusions [2][3][4][5].
- Malaysian and US guidance define some warning signs differently.
Why the Critical Phase Catches People Out
Dengue starts abruptly after an incubation period of 5–7 days. Fever typically lasts 2–7 days [1]. The danger comes as the temperature falls. The critical phase begins at defervescence and usually lasts 24–48 hours, during which plasma leakage can lead to shock within a few hours [1]. The Malaysian CPG notes it often occurs after the third day of fever, and may come earlier [4]. CDC places it typically 3–8 days after fever onset [2].
Severe dengue is defined by severe plasma leakage leading to shock or fluid accumulation with respiratory distress, severe bleeding, or severe organ impairment such as hepatitis with transaminases of 1,000 IU/L or more, impaired consciousness or myocardial involvement [1]. Shock in dengue often comes from leakage rather than overt bleeding [2]. Recurrent shock can occur because capillary leakage may continue for 24–48 hours [4].
Cases reported to WHO rose from 505,430 in 2000 to 14.6 million in 2024 [5]. A second infection carries a greater risk of severe dengue [5].
Confirming the Diagnosis
- Take a dengue rapid combo test or NS1 antigen as soon as dengue is suspected [4].
- NS1 sensitivity falls from day 4–5 of illness. IgM is usually positive only after day 5–7, so a negative IgM before then does not exclude dengue [4].
- If IgM is negative before day 7, repeat it in the recovery phase [4].
- Typical laboratory findings include leukopenia, thrombocytopenia, hyponatraemia and raised AST and ALT [1].
- Record a baseline haematocrit (HCT) and white cell count at the first visit, then monitor serial full blood counts [4].
Warning Signs: Malaysia and the US Compared
| Warning sign | MOH Malaysia CPG (2015) [4] | CDC [2] |
|---|---|---|
| Abdominal pain | Any abdominal pain or tenderness | Severe abdominal pain or tenderness |
| Vomiting | Persistent: more than 3 times over 24 hours | Persistent: 3 or more in 1 hour, or 4 or more in 6 hours |
| Diarrhoea | Persistent: more than 3 times over 24 hours | Not listed |
| Fluid accumulation | Ascites, pleural or pericardial effusion | Ascites, pleural or pericardial effusion |
| Bleeding | Spontaneous bleeding tendency | Mucosal bleeding (gums, nose, vagina, kidney) |
| Mental state | Lethargy, restlessness or confusion | Irritability, drowsiness, GCS below 15 |
| Liver | Tender liver | Liver 2 cm or more below the costal margin |
| Haematocrit | Raised HCT with a rapid drop in platelets (HCT 46% in men under 60, 42% in men over 60, 40% in women) | Progressive rise in at least 2 consecutive measurements 6 hours apart |
The Malaysian list is more inclusive: any abdominal pain and persistent diarrhoea both count.
When to Admit
The Malaysian CPG warns that admission must not rest on a single clinical parameter [4]. Admit or refer when any of the following apply:
- Symptoms: warning signs, bleeding, inability to tolerate oral fluids, reduced urine output or seizure [4].
- Signs: dehydration, shock, bleeding or any organ failure [4].
- Laboratory: rising HCT with a falling platelet count [4].
- Special situations: pregnancy; age over 65; diabetes, hypertension, ischaemic heart disease, coagulopathy, morbid obesity, renal failure, chronic liver disease or COPD; antiplatelet or anticoagulant use; and social factors that make follow-up difficult, such as living far away, having no transport or living alone [4].
CDC takes a similar line. Patients with warning signs should be managed as inpatients. Without warning signs, pregnancy, acute renal failure, coagulopathy, breathlessness or inability to take oral fluids also call for admission. Other comorbidities, age under 1 or over 65, and poor access to care are judged case by case [2]. Severe dengue belongs in a unit capable of close monitoring and rapid fluid management, ideally intensive care [2].
Spotting Shock Early
Compensated shock is easy to miss because the systolic pressure stays normal. Look for capillary refill over 2 seconds, cool extremities, weak thready pulses, tachycardia, a raised diastolic pressure, postural hypotension, tachypnoea and reduced urine output [4]. A compensated metabolic acidosis is an early sign [4].
The guidelines differ on pulse pressure. CDC lists a pulse pressure below 20 mmHg among the signs of early shock [3]. The Malaysian CPG describes a pulse pressure below 20 mmHg and systolic pressure below 90 mmHg as late signs of shock in adults [4]. Do not wait for hypotension.
Fluids
For a patient managed at home, the Malaysian CPG advises 2–3 litres of oral fluid a day [4].
For dengue with warning signs but no shock, the Malaysian CPG uses 0.9% saline at 5 mL/kg/hour for 1–2 hours, then 3 mL/kg/hour for 2–4 hours, then 2 mL/kg/hour or less, aiming for urine output of 0.5–1.0 mL/kg/hour [4]. CDC advises an initial isotonic crystalloid bolus, normal saline or Ringer’s lactate, reduced gradually as the patient improves [2]. CDC monitors HCT every 4–6 hours in this group [2]; the Malaysian CPG checks the full blood count 4–12 hourly in the critical phase [4].
For decompensated shock, both give 20 mL/kg over 15–30 minutes and then reassess [3][4]. Crystalloid is the preferred fluid in dengue shock [4]. CDC advises considering colloid such as albumin when the patient does not respond to 2–3 boluses [2]. Check HCT before and after each fluid bolus [3][4]. Avoid half-normal saline, which may worsen effusions and ascites [3].
IV fluids can usually stop 24–48 hours after defervescence, or when HCT falls in a stable patient [4]. In the recovery phase the patient reabsorbs leaked fluid, so continued infusion risks fluid overload [1][2].
Drugs and Blood Products
- Analgesia and fever: paracetamol. CDC advises dosing at 6-hour intervals, no more than 4 doses a day [3]. Avoid NSAIDs and aspirin because of bleeding risk [2][5]. Avoid other potentially hepatotoxic drugs [4].
- Platelets and plasma: thrombocytopenia and coagulation abnormalities do not reliably predict bleeding. There is no role for routine prophylactic platelet or plasma transfusion [4]. CDC agrees [2][3].
- Before procedures: the Malaysian CPG reserves prophylactic blood products for when an invasive procedure or operation has been decided [4].
- Corticosteroids: not routine [2].
Outpatient Follow-Up and Discharge
Outpatients need daily review, especially from day 3 of illness, until they have been afebrile for at least 24–48 hours without antipyretics [4]. Give clear return advice: severe abdominal pain, persistent vomiting, bleeding from the gums or nose, black stools, drowsiness or irritability, cold clammy skin or difficulty breathing [3].
CDC’s discharge criteria for admitted patients include no fever for 48 hours without antipyretics, improved appetite, normal vital signs, adequate urine output, normal breathing, no bleeding, a rising platelet count and a stable HCT without IV fluids [3].
For Primary Care and Dental Teams
Patients with dengue may first present to a GP, or to a dentist with bleeding gums. In an endemic area, ask about fever in the past week before attributing gingival bleeding to local causes, and refer a febrile patient with mucosal bleeding for same-day assessment. Patients on antiplatelets or anticoagulants have a lower threshold for admission [4]. Our guide to anticoagulants and antiplatelets before dental extraction covers how these drugs affect bleeding risk in general.
Ask BossCE AI
Ask BossCE AI a follow-up question, such as how to adjust fluids for an obese or pregnant patient with dengue, and check each numbered source for yourself.
Sources
- Centers for Disease Control and Prevention. Clinical Features of Dengue. Updated 24 February 2026. cdc.gov
- Centers for Disease Control and Prevention. Clinical Care of Dengue. Updated 15 April 2026. cdc.gov
- Centers for Disease Control and Prevention. Dengue Clinical Management Pocket Guide: Dengue Case Management. 2024. cdc.gov
- Ministry of Health Malaysia. Clinical Practice Guidelines: Management of Dengue Infection in Adults. 3rd ed. 2015. moh.gov.my
- World Health Organization. Dengue and Severe Dengue. Fact sheet, 21 August 2025. who.int
This article is for qualified healthcare professionals and is not a substitute for clinical judgement or the full guideline. Check the current version of each source before applying it.

